How to Perform a Kirby-Bauer Disk Diffusion Susceptibility Test: Protocol and Interpretation

The Kirby-Bauer disk diffusion susceptibility test, also known as the disk diffusion method, is a standardized laboratory technique used to determine the susceptibility or resistance of a bacterial isolate to antimicrobial agents. This method involves placing antibiotic-impregnated disks on an agar plate inoculated with a standardized bacterial suspension; after incubation, the diameter of the zone of inhibition around each disk is measured and interpreted against published breakpoints. The Kirby-Bauer test is most useful for rapidly growing, non-fastidious bacteria and is a cornerstone of routine antimicrobial susceptibility testing in teaching, research, and clinical microbiology laboratories. It provides a qualitative (susceptible, intermediate, or resistant) result that guides treatment decisions and surveillance of antimicrobial resistance patterns.

At a Glance

Scientific Principle

The Kirby-Bauer disk diffusion test relies on the diffusion of an antibiotic from a paper disk into the surrounding agar medium. When a bacterial inoculum is spread uniformly across the agar surface, bacterial growth occurs everywhere except where the antibiotic concentration exceeds the minimum inhibitory concentration (MIC) for that organism. The resulting clear area around the disk is called the zone of inhibition. The diameter of this zone is inversely related to the MIC: larger zones indicate greater susceptibility (lower MIC), while smaller or absent zones indicate resistance (higher MIC). The test is standardized by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST), which provide breakpoint tables for interpreting zone diameters for specific organism-antimicrobial combinations. The method is based on the principle that antibiotic diffusion follows a logarithmic concentration gradient, and the zone edge corresponds to the critical concentration that inhibits visible growth.

Materials and Instrumentation

Essential Materials

• Mueller-Hinton agar (MHA): The standard medium for disk diffusion. It supports the growth of most non-fastidious bacteria and provides consistent diffusion properties. For fastidious organisms (e.g., Streptococcus pneumoniae, Haemophilus influenzae), supplemented MHA (e.g., with 5% sheep blood or 1% hemoglobin and 1% IsoVitaleX) is required.
• Antibiotic disks: Commercially prepared, sterile paper disks impregnated with defined concentrations of antimicrobial agents. Store at 2–8°C in sealed containers with desiccant. Allow disks to warm to room temperature before use to prevent condensation.
• McFarland turbidity standard: A 0.5 McFarland standard (approximately 1.5 × 10⁸ CFU/mL for E. coli) is used to standardize the inoculum. Commercial standards or a barium sulfate suspension can be used.
• Sterile cotton swabs: For inoculum application.
• Forceps or disk dispenser: For placing disks on the agar surface.
• Calipers or ruler: For measuring zone diameters. A ruler with millimeter markings is acceptable; calipers provide greater precision.
• Incubator: Set to 35 ± 2°C, ambient air. For some organisms (e.g., S. pneumoniae), 5% CO₂ is required.

Optional Equipment

• Vortex mixer: For homogenizing bacterial suspensions.
• Spectrophotometer: Can be used to verify inoculum density if a McFarland standard is unavailable.
• Automated zone reader: For high-throughput laboratories, but manual measurement remains the gold standard.

Quality Control Strains

• Escherichia coli ATCC 25922: For Gram-negative quality control.
• Staphylococcus aureus ATCC 25923: For Gram-positive quality control.
• Pseudomonas aeruginosa ATCC 27853: For Pseudomonas and certain antibiotics.
• Enterococcus faecalis ATCC 29212: For vancomycin and other agents.

Controls

Positive Controls

• Quality control (QC) strains: Test known susceptible strains (e.g., E. coli ATCC 25922) alongside clinical isolates. Zone diameters must fall within published acceptable ranges. If QC results are out of range, the test is invalid and must be repeated.

Negative Controls

• Blank disk: Place a sterile, antibiotic-free disk on the inoculated plate. No zone of inhibition should appear. A zone indicates contamination or intrinsic inhibition by the disk material.
• Uninoculated plate: Incubate an uninoculated MHA plate to verify sterility of the medium.

Internal Controls

• Inoculum verification: Confirm that the bacterial suspension matches the 0.5 McFarland standard. Under- or over-inoculation alters zone sizes.
• Medium depth: MHA should be poured to a uniform depth of 4 mm (approximately 25 mL per 100 mm plate). Thicker agar reduces diffusion and produces smaller zones.
• Disk placement: Disks should be placed no closer than 24 mm from center to center (typically 15–20 mm from the plate edge) to prevent overlapping zones.

Conceptual Workflow

Step 1: Inoculum Preparation

1. Select 3–5 well-isolated colonies of the test organism from an 18–24 hour culture on non-selective agar (e.g., blood agar or tryptic soy agar).
2. Transfer colonies to 2–3 mL of sterile saline or Mueller-Hinton broth using a sterile loop or swab.
3. Vortex or mix thoroughly to create a homogeneous suspension.
4. Adjust the turbidity to match a 0.5 McFarland standard. This can be done visually against a white background with a comparison card or using a nephelometer. If the suspension is too turbid, add more sterile diluent; if too light, add more colonies.
5. Use the suspension within 15 minutes to avoid changes in cell density.

Step 2: Inoculation of Agar

1. Dip a sterile cotton swab into the adjusted suspension. Rotate the swab against the tube wall above the liquid to remove excess fluid.
2. Streak the swab evenly across the entire surface of the MHA plate in three directions (e.g., horizontal, vertical, and diagonal) to ensure confluent growth.
3. Rotate the plate approximately 60 degrees between each streaking direction.
4. Allow the plate surface to dry for 3–5 minutes (no longer than 15 minutes) before applying disks. The plate should appear uniformly moist but without visible droplets.

Step 3: Disk Application

1. Using sterile forceps or a disk dispenser, apply antibiotic disks firmly onto the agar surface. Press gently to ensure full contact; do not embed the disk into the agar.
2. Place disks at least 24 mm apart (center to center) and at least 15 mm from the plate edge. A standard 100 mm plate can accommodate 5–6 disks; a 150 mm plate can hold up to 12 disks.
3. Record the position of each disk on the plate lid or in a laboratory notebook.
4. Invert plates and incubate at 35 ± 2°C for 16–24 hours in ambient air. For fastidious organisms, use appropriate atmosphere (e.g., 5% CO₂ for S. pneumoniae).

Step 4: Zone Measurement

1. After incubation, examine the plate for confluent growth. If growth is patchy or insufficient, the test must be repeated.
2. Measure the diameter of each zone of inhibition to the nearest millimeter using a ruler or calipers. Measure across the center of the disk, including the disk itself. For swarming organisms (e.g., Proteus spp.), measure the zone edge where growth is clearly inhibited, ignoring the swarming haze.
3. Read zones against a dark, non-reflective background with transmitted light. For better visualization, hold the plate a few inches above a black surface with overhead illumination.
4. Record zone diameters in the laboratory record.

Step 5: Interpretation

1. Compare measured zone diameters to CLSI or EUCAST breakpoint tables for the specific organism-antimicrobial combination.
2. Classify each result as Susceptible (S), Intermediate (I), or Resistant (R).
3. For organisms not listed in breakpoint tables, the test is considered investigational and results should be reported as "no interpretation" or with a disclaimer.

Quality Checks

Pre-Test Quality Checks

• Verify that MHA plates are within expiration date and free of contamination, cracks, or excessive moisture.
• Confirm that antibiotic disks are within expiration date and stored properly.
• Check that the McFarland standard is not expired and has been vortexed before use.
• Ensure the incubator temperature is within 35 ± 2°C.

During-Test Quality Checks

• Inoculum density should be verified by a second person if possible.
• Disk placement should be checked for proper spacing.
• Record the time between inoculation and disk application (should not exceed 15 minutes).

Post-Test Quality Checks

• Examine QC strain zones. All must fall within published acceptable ranges. If any QC result is out of range, the entire run is invalid.
• Check for confluent growth on the test plate. If growth is too light or too heavy, repeat the test.
• Verify that zones are circular and clearly defined. Irregular zones may indicate contamination or technical error.

Result Interpretation

Zone Diameter Measurement

• Measure the diameter of the zone of inhibition, including the disk, to the nearest millimeter.
• For disks with no zone, record as 6 mm (the disk diameter).
• For pinpoint colonies within a zone (e.g., resistant subpopulations), measure the inner zone of complete inhibition.

Breakpoint Interpretation

• Use the most current CLSI M100 (for human clinical isolates) or EUCAST breakpoint tables.
• Example breakpoints for S. aureus and cefoxitin (30 μg disk):
  • ≥22 mm: Susceptible (methicillin-susceptible S. aureus, MSSA)
  • ≤21 mm: Resistant (methicillin-resistant S. aureus, MRSA)
• Example breakpoints for E. coli and ciprofloxacin (5 μg disk):
  • ≥26 mm: Susceptible
  • 22–25 mm: Intermediate
  • ≤21 mm: Resistant

Reporting Results

• Report each antibiotic as S, I, or R.
• For intermediate results, the antibiotic may be effective at higher doses or at body sites where concentrations are high (e.g., urine).
• Do not report results for antibiotics that are not appropriate for the organism (e.g., vancomycin for Gram-negative bacilli).

Common Pitfalls

• Swarming organisms: Proteus spp. may swarm across the plate. Measure the zone at the edge of confluent growth, ignoring the swarming haze.
• Beta-lactamase production: Some organisms (e.g., S. aureus) may produce beta-lactamase that degrades penicillin, resulting in a sharp, clear zone edge. This is normal and should be measured as usual.
• Double zones: Occasionally, a hazy inner zone may appear within a clear outer zone. Measure the outer zone edge.

Troubleshooting

Limitations

• Qualitative results only: The Kirby-Bauer test provides S/I/R classification, not an MIC value. For quantitative MIC determination, broth dilution or Etest methods are required.
• Not suitable for all organisms: Slow-growing bacteria (e.g., Mycobacterium spp.), fastidious organisms (e.g., Neisseria gonorrhoeae, Haemophilus influenzae), and anaerobes require specialized media and conditions.
• Medium dependency: Results are influenced by agar composition, pH, depth, and cation content. Only Mueller-Hinton agar (or its supplements) is recommended.
• Disk stability: Antibiotic disks degrade over time, especially if exposed to moisture or temperature fluctuations. Always check expiration dates and storage conditions.
• Interpretation variability: Different breakpoint organizations (CLSI vs. EUCAST) may yield different interpretations for the same zone diameter. Always specify which breakpoints are used.
• No detection of inducible resistance: Some resistance mechanisms (e.g., inducible clindamycin resistance in S. aureus) require additional tests (e.g., D-zone test) for detection.
• Not for direct testing of clinical specimens: The test requires a pure culture. Direct testing of urine or other specimens is not standardized.

Documentation

Required Records

• Date and time of test
• Organism identification and source
• Inoculum density verification (McFarland reading)
• Medium lot number and expiration date
• Antibiotic disk lot numbers and expiration dates
• QC strain results (zone diameters and interpretation)
• Test organism zone diameters for each antibiotic
• Interpretation (S/I/R) for each antibiotic
• Incubator temperature check
• Technician initials

Reporting Format

• Report results as Susceptible (S), Intermediate (I), or Resistant (R) for each antibiotic tested.
• Include the breakpoint source (e.g., CLSI M100, 2024).
• For research or teaching purposes, report zone diameters in millimeters.
• Flag any results that are outside the normal range or require confirmation.

Archival

• Retain records for at least the period specified by institutional policy (typically 2–5 years).
• Store digital records in a secure, backed-up system.
• For clinical laboratories, follow local regulatory requirements for record retention.

Biosafety Considerations

Risk Assessment

• The Kirby-Bauer test is routinely performed with BSL-1 organisms (e.g., E. coli K-12, S. aureus ATCC 25923) in teaching laboratories. For clinical isolates or known pathogens, BSL-2 practices are required.
• Always perform a risk assessment based on the organism being tested. Refer to the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition for guidance [6].

Standard Precautions

• Work in a biosafety cabinet (BSC) when handling clinical isolates or organisms of unknown risk.
• Wear appropriate personal protective equipment (PPE): lab coat, gloves, and eye protection.
• Decontaminate work surfaces before and after procedures with an appropriate disinfectant (e.g., 10% bleach or 70% ethanol).
• Dispose of all contaminated materials (plates, swabs, disks) in biohazard waste containers.

Specific Precautions

• Do not use the Kirby-Bauer test for select agents or organisms requiring BSL-3 containment without appropriate facility and training.
• For organisms that produce aerosols (e.g., during vortexing), perform steps in a BSC.
• Never pipette bacterial suspensions by mouth.
• Wash hands thoroughly after handling cultures.

Spill Management

• Cover spills with absorbent material and apply disinfectant.
• Allow contact time as per disinfectant instructions (typically 10–20 minutes).
• Dispose of cleanup materials as biohazard waste.
• Notify laboratory supervisor if the spill involves a known pathogen.

Frequently Asked Questions

1. Why is Mueller-Hinton agar the recommended medium for the Kirby-Bauer test?

Mueller-Hinton agar is specifically formulated for disk diffusion testing. It has low levels of sulfonamide, trimethoprim, and tetracycline inhibitors, consistent pH (7.2–7.4), and reproducible diffusion properties. The agar depth (4 mm) and cation content (calcium and magnesium) are standardized to ensure consistent zone sizes. Other media may produce different zone diameters, leading to incorrect interpretations.

2. Can I use the Kirby-Bauer test for fastidious organisms like Streptococcus pneumoniae?

Yes, but modifications are required. For S. pneumoniae, use Mueller-Hinton agar supplemented with 5% defibrinated sheep blood and incubate in 5% CO₂. For Haemophilus influenzae, use Haemophilus Test Medium (HTM). Always use the appropriate breakpoint tables for these organisms, as standard MHA breakpoints do not apply.

3. What should I do if my QC strain results are out of range?

If any QC strain zone diameter falls outside the published acceptable range, the entire test run is invalid. Do not report any results. Common causes include expired disks or medium, incorrect inoculum density, improper incubation conditions, or contamination. Repeat the test with fresh QC strains, new disks, and freshly prepared medium. Document the out-of-range result and corrective action taken.

4. How do I interpret zones for swarming organisms like Proteus mirabilis?

Swarming organisms can produce a haze of growth that extends beyond the true zone of inhibition. Measure the zone at the edge of confluent growth, ignoring the swarming haze. For Proteus spp., some laboratories use swarming-inhibitory medium (e.g., MHA with increased agar concentration) to reduce swarming. Always report the method used in the documentation.

References and Further Reading

1. Alhadz GG, Salasia SIO, Lestari FB, et al. Occurrence, molecular confirmation, and multidrug resistance of methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in companion animals in Indonesia. 2026. PubMed ID: 41822594. Link – Provides context for Kirby-Bauer use in veterinary staphylococcal resistance surveillance.

2. B K P, Khadka S, Shrestha UT, Banjara MR. Detection of carbapenem resistance and its attributable genes in Acinetobacter baumannii isolated from cardiac patients at a referral cardiac hospital of Kathmandu. 2026. PubMed ID: 41507808. Link – Demonstrates Kirby-Bauer application for carbapenem resistance detection in clinical isolates.

3. Kaaya J, Manguzu MA, Buma D, et al. Urinary tract infections, risk factors and antimicrobial resistance patterns in heart failure patients on sodium-glucose transporter 2 inhibitors: Evidence from Jakaya Kikwete Cardiac Institute in Tanzania. 2026. PubMed ID: 41886421. Link – Illustrates Kirby-Bauer use for uropathogen susceptibility testing per CLSI guidelines.

4. Li H, Qian Z, Luo L, et al. Isolation, Identification and Pathogenicity Analysis of Proteus mirabilis in Cynomolgus Monkey From Yunnan, China. 2026. PubMed ID: 41954268. Link – Shows Kirby-Bauer application for Proteus species susceptibility testing.

5. Wataradee S, Suriyasathaporn W, Somsee M, et al. Herd Health Program Participation Associated with Lower Vancomycin Resistance and Multidrug Resistance in Dairy Mastitis Pathogens: A Five-Year Surveillance Study in Saraburi, Thailand. 2026. PubMed ID: 42187746. Link – Demonstrates longitudinal Kirby-Bauer surveillance in veterinary microbiology.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Link – Authoritative biosafety guidance for laboratory procedures.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Link – Biosafety framework for recombinant work.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Link – Searchable collection of biomedical methods references.

Related Articles

• How to Perform a Catalase Test: Principle, Procedure, and Interpretation
• How to Perform an Oxidase Test: Principle, Procedure, and Interpretation
• How to Perform an Indole Test: Principle, Procedure, and Interpretation
• How to Perform a Urease Test: Principle, Procedure, and Interpretation
• How to Perform a Coagulase Test: Slide and Tube Methods
• How to Perform a Citrate Utilization Test: Simmons Citrate Agar Protocol